Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a Parkinsonian rat model associated with depression
Objective: The objective of this study was to investigate how fluvoxamine maleate treatment regulates depressive-like symptoms, motor impairments and the expressions of IL-1beta, IL-6, IL-10…The impact of Parkinson’s disease on faith and spirituality
Objective: The objective of the present study is to assess the impact of Parkinson’s disease on faith and spirituality. Background: There are some controversies on…Olfaction and gustation in patients with Parkinson’s Disease
Objective: This study investigates smell and taste function in patients with Parkinson’s Disease (PD). Background: Up to 90% of patients with PD suffer from olfactory…Neuroanatomical correlates of depressive symptoms in newly diagnosed Parkinson’s disease patients
Objective: Depression is the most frequent neuropsychiatric manifestation in Parkinson's disease (PD). Although evidence suggests that depression in PD is related to the degenerative process…Central Aortic Pressure in Parkinson’s Disease and Levodopa Effect
Objective: Central aortic pressure (CAP) is the systolic blood pressure at the root of the aorta. In young people CAP is lower than the peripheral…Pain and Parkinson’s disease
Objective: We aimed to explore clinical correlates and risk factors in the development of pain, alongside the relationship between pain and striatal dopaminergic dysfunction in…Non-motor symptoms in Parkinsons’s disease patients treated with levodopa-carbidopa intestinal gel infusion- the follow up study
Objective: To follow up the effect of continuous levodopa-carbidopa intestinal gel infusion (LCIG) on motor and non-motor symptoms in advanced Parkinson’s disease (aPD). Background: Non-motor…Association of pain and depression with Parkinson’s disease-osteoarthritis comorbidity.
Objective: The goal of this study was to observe if additional pain associated with comorbid symptomatic OA in PD patients is correlated with greater depression…Cognitive Impairment in MSA Patients from the Catalan Multiple System Atrophy Registry (CMSAR)
Objective: To assess the cognitive function and its demographic and clinical correlates in MSA patients included in the Catalan Multiple System Atrophy-Registry (CMSAR). Background: Cognitive…Impulse control disorders in Parkinson’s disease; description of a New Zealand cohort
Objective: Impulse control disorders (ICDS) are a recognised complication of dopaminergic therapy for Parkinson’s disease. We wanted to assess the rates of ICDs in New…
- « Previous Page
- 1
- …
- 106
- 107
- 108
- 109
- 110
- …
- 155
- Next Page »